In addition, some studies suggest TERT promoter mutations are among the earliest genetic events in bladder cancer [41], thyroid carcinoma [42], cutaneous melanoma [14,43,44], basal cell and squamous cell carcinoma [45] and oligodendroglioma [46]. This evidence concerns the gene TERT and oligodendroglioma.